Skip to content
Medical Health Aged Care, Seniors Interest

Australian aged care residents seven times more likely to be taking painkiller medications when compared with Japan

Monash University 2 mins read

A new study from Monash University, in collaboration with Japan’s Institute for Health Economics and Policy, has revealed that only 11 per cent of Japanese aged care facility residents are prescribed regular painkiller medications, compared to nearly three-quarters (74 per cent) of Australia’s aged care facility population.  

Furthermore, the use of opioid painkiller medicines in aged care facilities was found to be 30-fold higher in Australia.

The study, published in the medical journal Age and Ageing and led by Monash’s Centre for Medicine Use and Safety (CMUS) within the Monash Institute of Pharmaceutical Sciences (MIPS), compared painkiller use among two samples of Australian and Japanese residents with the goal to better understand the pharmacological management of pain in residential aged care.

The painkiller medicines in most regular use include oral acetaminophen (paracetamol), non-steroidal anti-inflammatory drugs (e.g. ibuprofen), or opioids.

Qualitative data obtained through focus groups with Australian and Japanese health care professionals highlighted the differences in therapeutic goals, painkiller regulations and treatment durations between the two countries.

The study’s lead author Ms Laura Dowd, a pharmacist and CMUS PhD candidate, said these differences may explain the disparities in painkiller use between the respective countries.

“Australian participants described their therapeutic goal was to alleviate pain and reported painkillers were often prescribed on a regular basis, whilst Japanese participants described their therapeutic goal was to minimise impacts of pain on daily activities and reported opioid painkillers were prescribed for short-term durations, corresponding to episodes of pain,” Ms Dowd said.

“Australia and Japan both have rapidly ageing populations but appear to have very different patterns of painkiller use. Understanding these differences can inform new initiatives to improve pain management.”

Senior author and CMUS Research Fellow Dr Amanda Cross said, “This study confirms previous CMUS research that shows up to one-third of Australian residents are prescribed opioid painkiller medicines and highlights key areas where on-site aged care pharmacists could work to support the appropriate use of opioids.”

Dr Shota Hamada from the Institute for Health Economics and Policy in Tokyo said, “Painkillers are one component of an effective pain management strategy. Understanding the different role of painkillers as part of the overall approach to pain management will help the safe and effective painkiller use.”

To read the full study visit https://academic.oup.com/ageing/article/53/2/afae024/7614404 

https://doi.org/10.1093/ageing/afae024 

ENDS


Contact details:

Kate Carthew, Media and Communications Manager, Monash University.

[email protected] 

Media

More from this category

  • CharitiesAidWelfare, Medical Health Aged Care
  • 14/02/2026
  • 06:00
Leukaemia Foundation

International Childhood Cancer Day highlights blood cancer as the biggest cancer threat to Australian children

Blood cancer is the most commonly diagnosed childhood cancer in Australia[i] – and its growing impact is robbing far too many young Australians of…

  • Contains:
  • Medical Health Aged Care
  • 13/02/2026
  • 13:36
Royal Australian College of GPs

RACGP calls on SA Government to ensure evidence-based approach to primary care reforms

The Royal Australian College of GPs (RACGP) has called on the SA Government to match the position laid out by Liberal health spokesperson Heidi Girolamo on the role of pharmacists and GPs in primary care, emphasising the importance of safe, coordinated and evidence-based models that support the best outcomes for South Australians. RACGP SA Chair Dr Sian Goodson said the SA Liberal’s position highlights the need for careful consideration of how different parts of the health system interact. “There is currently no serious evidence base supporting pharmacy prescribing trials, and that lack of rigorous data raises real concerns about patient…

  • Contains:
  • Medical Health Aged Care
  • 13/02/2026
  • 11:02
Royal Australian College of GPs

Convenience can’t come at the cost of safety: RACGP calls for safeguards on WA pharmacy pilot

The Royal Australian College GPs (RACGP) has called for guardrails to protect patient safety, following a WA Government announcement that a further 40 pharmacists will commence training this monthto diagnose and treat Western Australians for a range of conditions as part of the Enhanced Access Community Pharmacy Pilot. RACGP WA Chair Dr Ramya Raman said GPs support innovation, but any reforms must strike the right balance between improving access and ensuring quality patient care. “Patients deserve convenience and safety. We support innovation, but diagnosis, follow-up and continuity aren’t optional extras,” she said. “These safeguards exist for a reason, to catch…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.